NASDAQ:IDXX - Nasdaq - US45168D1046 - Common Stock - Currency: USD
452.77
-0.09 (-0.02%)
The current stock price of IDXX is 452.77 USD. In the past month the price increased by 4.73%. In the past year, price decreased by -21.43%.
Symbol | Name | TA | FA | PE | Market Cap |
---|---|---|---|---|---|
ABT | ABBOTT LABORATORIES | 28.89 | 234.01B | ||
ISRG | INTUITIVE SURGICAL INC | 80.74 | 211.07B | ||
BSX | BOSTON SCIENTIFIC CORP | 41.63 | 154.00B | ||
SYK | STRYKER CORP | 31.4 | 145.92B | ||
MDT | MEDTRONIC PLC | 16.84 | 115.33B | ||
BDX | BECTON DICKINSON AND CO | 16.35 | 65.30B | ||
EW | EDWARDS LIFESCIENCES CORP | 27.98 | 43.23B | ||
GEHC | GE HEALTHCARE TECHNOLOGY | 20.29 | 41.62B | ||
DXCM | DEXCOM INC | 53.81 | 34.68B | ||
RMD | RESMED INC | 26.21 | 34.03B | ||
PHG | KONINKLIJKE PHILIPS NVR- NY | 17.5 | 24.02B | ||
STE | STERIS PLC | 24.03 | 21.67B |
IDEXX Laboratories, Inc. engages in the development, manufacture, and distribution of products and services for the animal veterinary, livestock and poultry, dairy, and water testing markets. The company is headquartered in Westbrook, Maine and currently employs 11,000 full-time employees. The firm also provides human medical point-of-care and laboratory diagnostics. Its segments include Companion Animal Group (CAG), Water quality products (Water), and Livestock, Poultry and Dairy (LPD). The CAG segment offers diagnostic and information management-based products and services for the companion animal veterinary industry, including in-clinic diagnostic solutions, outside reference laboratory services, and veterinary software and services. Its Water segment provides testing solutions for accurate detection and quantification of various microbiological parameters in water. Its LPD segment provides diagnostic tests, services, and related instrumentation that are used to manage the health status of livestock and poultry, to improve the quality and safety of milk.
IDEXX LABORATORIES INC
One Idexx Drive
Westbrook MAINE 04092 US
CEO: Jonathan J. Mazelsky
Employees: 11000
Company Website: https://www.idexx.com/
Investor Relations: https://www.idexx.com/en/about-idexx/investors/
Phone: 12075560300
The current stock price of IDXX is 452.77 USD. The price decreased by -0.02% in the last trading session.
The exchange symbol of IDEXX LABORATORIES INC is IDXX and it is listed on the Nasdaq exchange.
IDXX stock is listed on the Nasdaq exchange.
21 analysts have analysed IDXX and the average price target is 499.57 USD. This implies a price increase of 10.34% is expected in the next year compared to the current price of 452.77. Check the IDEXX LABORATORIES INC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
IDEXX LABORATORIES INC (IDXX) has a market capitalization of 37.07B USD. This makes IDXX a Large Cap stock.
IDEXX LABORATORIES INC (IDXX) currently has 11000 employees.
IDEXX LABORATORIES INC (IDXX) has a support level at 452.74 and a resistance level at 455.57. Check the full technical report for a detailed analysis of IDXX support and resistance levels.
The Revenue of IDEXX LABORATORIES INC (IDXX) is expected to grow by 6.44% in the next year. Check the estimates tab for more information on the IDXX EPS, Sales, EBIT and EBITDA future analyst estimates.
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
IDXX does not pay a dividend.
IDEXX LABORATORIES INC (IDXX) will report earnings on 2025-05-01, before the market open.
The PE ratio for IDEXX LABORATORIES INC (IDXX) is 40.25. This is based on the reported non-GAAP earnings per share of 11.25 and the current share price of 452.77 USD. Check the full fundamental report for a full analysis of the valuation metrics for IDXX.
The outstanding short interest for IDEXX LABORATORIES INC (IDXX) is 2.41% of its float. Check the ownership tab for more information on the IDXX short interest.
ChartMill assigns a technical rating of 5 / 10 to IDXX. When comparing the yearly performance of all stocks, IDXX is a bad performer in the overall market: 72.87% of all stocks are doing better.
ChartMill assigns a fundamental rating of 6 / 10 to IDXX. IDXX scores excellent on profitability, but there are some minor concerns on its financial health.
Over the last trailing twelve months IDXX reported a non-GAAP Earnings per Share(EPS) of 11.25. The EPS increased by 11.72% compared to the year before.
Industry Rank | Sector Rank | ||
---|---|---|---|
PM (TTM) | 22.78% | ||
ROA | 26.96% | ||
ROE | 55.65% | ||
Debt/Equity | 0.44 |
ChartMill assigns a Buy % Consensus number of 77% to IDXX. The Buy consensus is the average rating of analysts ratings from 21 analysts.
For the next year, analysts expect an EPS growth of 8.68% and a revenue growth 6.44% for IDXX